SPI-77

SPI-77

Oncology A liposomal formulation of cisplatin used to manage advanced CA unresponsive to other treatment. See Cisplatin.
References in periodicals archive ?
AMPHOTEC and SPI-77 products and for the development and execution of strategies for registration of the SEQUUS pipeline products.
NASDAQ:SEQU) today announced the opening of a Phase I clinical trial of SPI-77 in the treatment of solid tumors.
the Phase I study is focused on determining the maximum tolerated dose of SPI-77 and establishing the toxicity profile of SPI-77 in patients with advanced malignancies not amenable to other cancer treatment.
Food and Drug Administration (FDA) for clinical testing of SPI-77 in the treatment of solid tumors.
It is a tribute to our entire team working on SPI-77 that we have filed this IND ahead of schedule," said Minick.
Preclinical studies indicate that SPI-77 has an extended half-life in the blood of 29.